Elevating MRI to a Real-time Monitor of Cell Health

Rockland Technimed Limited is a diagnostic imaging company, committed to the early diagnosis and treatment of ischemic injury, through its patented Oxy-17® metabolic magnetic resonance imaging medium.
Read More

End of year sale on OxyGas  


Rockland Technimed, Ltd. presents Oxy-17® at the 20th Annual Meeting of the International Society for Magnetic Resonance Imaging in Medicine (ISMRM)



Message from the CEO

Discover Oxy-17®

Oxy-17® is is the only non-radioactive imagimg medium to measure real-time oxygen metabolism, oxygen extraction fraction and molecular oxygen consumption using an unaltered clinical MRI scanner.